Investigation of iodine contrast medium amount of reduction in the pulmonary arteriovenous isolation 3D-CT angiography

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1091220254

Enrollment

100

Registered

2016-07-22

Start date

2016-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

Intervention type:DRUG Name of intervention: Non-ionic iodinated contrast agent Dose form / Japanese Medical Device Nomenclature:INJECTION Route of administration / Site of application:INTRAVENOUS BOL

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Cases of pulmonary arteriovenous CT examination

Exclusion criteria

Exclusion criteria: Cases of principal investigator has determined that exclusion

Design outcomes

Primary

Measure	Time frame
Pulmonary arteriovenous of the 3D image. Intravascular CT value.	—

Countries

Japan

Contacts

Public ContactJun Nakane

Saitama medical center

jun_n@saitamad.ac.jp+81-49-228-3400

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026